<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Acquired Immunodeficiency Syndrome - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
            --banner-bg: #fef3c7;
            --banner-border: #f59e0b;
            --banner-text: #92400e;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .notice-banner {
            background: var(--banner-bg);
            color: var(--banner-text);
            border-bottom: 1px solid var(--banner-border);
            padding: 12px 16px;
            text-align: center;
            font-size: 0.95rem;
            cursor: pointer;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-location {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-component {
            background: #f0fdf4;
            color: #166534;
        }

        .tag-complex {
            background: #faf5ff;
            color: #7e22ce;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Phenotype TOC strip */
        .pheno-toc {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #e2e8f0;
            margin-bottom: 4px;
        }

        .pheno-toc-pill {
            display: inline-block;
            font-size: 0.78rem;
            padding: 3px 10px;
            border-radius: 12px;
            background: #dcfce7;
            color: #166534;
            text-decoration: none;
            cursor: pointer;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toc-pill:hover {
            background: #bbf7d0;
        }

        .pheno-toc-pill .pill-count {
            font-weight: 600;
            margin-left: 2px;
        }

        .pheno-toggle-all {
            font-size: 0.78rem;
            color: #16a34a;
            cursor: pointer;
            background: none;
            border: 1px solid #bbf7d0;
            border-radius: 6px;
            padding: 3px 10px;
            margin-left: auto;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toggle-all:hover {
            background: #f0fdf4;
        }

        /* Collapsible category groups */
        .phenotype-category-group {
            margin-bottom: 2px;
        }

        .phenotype-category-group summary {
            font-size: 0.85rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #16a34a;
            margin: 0;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #bbf7d0;
            cursor: pointer;
            list-style: none;
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .phenotype-category-group summary::-webkit-details-marker {
            display: none;
        }

        .phenotype-category-group summary .chevron {
            display: inline-block;
            width: 16px;
            height: 16px;
            transition: transform 0.15s;
            flex-shrink: 0;
        }

        .phenotype-category-group[open] summary .chevron {
            transform: rotate(90deg);
        }

        .phenotype-category-group summary .cat-count {
            font-size: 0.75rem;
            font-weight: 400;
            color: #15803d;
            background: #dcfce7;
            padding: 1px 7px;
            border-radius: 8px;
        }

        /* Phenotype Contexts */
        .phenotype-contexts {
            margin-top: 10px;
        }

        .phenotype-contexts-toggle {
            font-size: 0.8rem;
            color: var(--text-muted);
            cursor: pointer;
            user-select: none;
        }

        .phenotype-contexts-toggle:hover {
            color: var(--primary);
        }

        .context-card {
            padding: 10px 14px;
            margin-top: 8px;
            border-radius: 8px;
            background: #ecfdf5;
            border: 1px solid #a7f3d0;
            font-size: 0.88rem;
        }

        .context-header {
            display: flex;
            flex-wrap: wrap;
            align-items: center;
            gap: 6px;
            margin-bottom: 6px;
        }

        .context-label {
            font-size: 0.72rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            padding: 2px 8px;
            border-radius: 4px;
        }

        .context-label-genetic {
            background: #dbeafe;
            color: #1e40af;
        }

        .context-label-sex {
            background: #fce7f3;
            color: #9d174d;
        }

        .context-label-population {
            background: #fef3c7;
            color: #92400e;
        }

        .context-label-age {
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-label-subtype {
            background: #ede9fe;
            color: #5b21b6;
        }

        .context-label-frequency {
            background: #dcfce7;
            color: #166534;
        }

        .context-gene-list {
            display: flex;
            flex-wrap: wrap;
            gap: 4px;
            margin: 4px 0;
        }

        .context-gene-tag {
            font-size: 0.78rem;
            font-weight: 600;
            padding: 1px 8px;
            border-radius: 4px;
            background: #bfdbfe;
            color: #1e3a8a;
        }

        .context-detail {
            font-size: 0.84rem;
            color: #065f46;
            line-height: 1.5;
        }

        .context-detail strong {
            color: #047857;
        }

        .context-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #bbf7d0;
            color: #14532d;
            font-weight: 600;
        }

        .context-onset {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-severity {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #fef3c7;
            color: #92400e;
        }

        .context-notes {
            font-size: 0.84rem;
            color: #065f46;
            margin-top: 4px;
            line-height: 1.5;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }
        .classification-header {
            font-size: 1rem;
            font-weight: 600;
            color: #4338ca;
            margin: 1.2rem 0 0.5rem 0;
            padding-bottom: 0.3rem;
            border-bottom: 2px solid #c7d2fe;
            text-transform: capitalize;
        }
        .subtype-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 0.4rem;
            margin: 0.3rem 0;
        }
        .subtype-freq-badge {
            background: #dbeafe;
            color: #1e40af;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-gene-tag {
            background: #fef3c7;
            color: #92400e;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-inheritance-tag {
            background: #ede9fe;
            color: #5b21b6;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-term-link {
            font-size: 0.8rem;
            color: #6366f1;
            text-decoration: none;
        }
        .subtype-term-link:hover { text-decoration: underline; }
        .subtype-children {
            margin: 0.4rem 0 0.2rem 1rem;
            padding: 0;
            list-style: none;
        }
        .subtype-children li {
            font-size: 0.85rem;
            color: #4338ca;
            padding: 0.1rem 0;
        }
        .subtype-children li::before {
            content: "↳ ";
            color: #a5b4fc;
        }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <div class="notice-banner" role="button" tabindex="0">This resource is in its pre-alpha development stage. Content is actively being curated and may be incomplete or subject to change.</div>
    

    

    
    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Acquired Immunodeficiency Syndrome</span>
        </nav>

        <header class="page-header">
            <h1>Acquired Immunodeficiency Syndrome</h1>
            <div class="header-meta">
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0012268" target="_blank">
                        MONDO:0012268
                    </a>
                </span>
                
                
            </div>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
        <div class="stats-bar">
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Mappings</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Definitions</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Inheritance</div>
            </div>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">6</div>
                <div class="stat-label">Pathophysiology</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">6</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#genetic">
            <div class="stat-item">
                <div class="stat-value">8</div>
                <div class="stat-label">Genes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#subtypes">
            <div class="stat-item">
                <div class="stat-value">1</div>
                <div class="stat-label">Subtypes</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
            
        </div>

        <!-- Classifications -->
        

        <!-- Mappings -->
        

        <!-- Definitions -->
        

        <!-- Inheritance -->
        

        <!-- Subtypes -->
        
        <div class="card" id="subtypes">
            <div class="card-header">
                <div class="card-icon" style="background: #eef2ff; color: #4f46e5;">◆</div>
                <h2 class="card-title">Subtypes</h2>
                <span class="card-count">1</span>
            </div>
            
            
            
                
                
                    
                
                
            
            
                
                
                <div class="item-box subtype-box">
                    <div class="item-name">
                        AIDS-defining conditions
                        
                    </div>
                    <div class="subtype-meta">
                        
                        
                        
                    </div>
                    
                    <div class="item-desc">Presence of specific opportunistic infections or cancers signaling progression to AIDS.</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/3608570" target="_blank">PMID:3608570</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Aside from opportunistic infections, several neoplasms have been identified as part of the spectrum of acquired immunodeficiency syndrome (AIDS) as defined by the Centers for Disease Control."</div>
                
                
                <div class="evidence-explanation">The reference explicitly mentions that opportunistic infections and certain cancers (neoplasms) are part of the spectrum of AIDS, fitting the definition of AIDS-defining conditions provided in the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/18366449" target="_blank">PMID:18366449</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The three most frequent initial ADIs were Pneumocystis carinii (jirovecii) pneumonia (PCP) (15.6%), oesophageal candidiasis (14.3%) and Kaposi&#39;s sarcoma (13.9%) in the pre-cART period."</div>
                
                
                <div class="evidence-explanation">This reference discusses specific opportunistic infections and cancers as initial AIDS-defining illnesses (ADIs), supporting the assertion that these conditions signal progression to AIDS.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19584497" target="_blank">PMID:19584497</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Opportunistic parasitic infection can cause severe morbidity and mortality."</div>
                
                
                <div class="evidence-explanation">This reference highlights the role of opportunistic infections in patients with HIV/AIDS, which supports the statement about specific opportunistic infections being AIDS-defining conditions.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                </div>
                
            
        </div>
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">⚙</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">6</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">CD4 T-cell Depletion</div>
                
                <div class="item-desc">HIV infects and destroys CD4 T-cells, critical for immune system function.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        CD4 T-lymphocyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000624" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-gene">
                        CD4
                        
                        <a href="https://bioregistry.io/hgnc:1678" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-gene">
                        CCR5
                        
                        <a href="https://bioregistry.io/hgnc:1606" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-gene">
                        CXCR4
                        
                        <a href="https://bioregistry.io/hgnc:2561" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        reverse transcription
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0001171" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        DNA integration
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0015074" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        T cell activation
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0042110" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        lymph node
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0000029" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-location">
                        small intestine
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0002108" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23772614" target="_blank">PMID:23772614</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The hallmark of acquired immunodeficiency syndrome (AIDS) pathogenesis is a progressive depletion of CD4(+) T-cell populations in close association with progressive impairment of cellular immunity and increasing susceptibility to opportunistic infections (OI)."</div>
                
                
                <div class="evidence-explanation">The literature supports that the depletion of CD4 T-cells is a critical mechanism in the pathogenesis of AIDS.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/9730930" target="_blank">PMID:9730930</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"HIV-1 infects mononuclear cells using the CD4+ molecule... ongoing cellular destruction, leading to the characteristic immunodeficiency of AIDS and its opportunistic infections and neoplasms."</div>
                
                
                <div class="evidence-explanation">The literature affirms that HIV infects and destroys CD4 T-cells, leading to immunodeficiency.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/9735117" target="_blank">PMID:9735117</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The entry of one HIV virion into a human being has the potential to cause death by the inexorable replication of the virus within the principal T lymphocyte, the CD4+ T cell."</div>
                
                
                <div class="evidence-explanation">This reference supports the assertion that HIV infects and leads to the destruction of CD4 T-cells, which are crucial for immune function.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Immune System Collapse</div>
                
                <div class="item-desc">Progressive loss of CD4 T-cells leads to severe immunodeficiency.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        CD4 T-lymphocyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000624" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23772614" target="_blank">PMID:23772614</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The hallmark of acquired immunodeficiency syndrome (AIDS) pathogenesis is a progressive depletion of CD4(+) T-cell populations in close association with progressive impairment of cellular immunity and increasing susceptibility to opportunistic infections (OI)."</div>
                
                
                <div class="evidence-explanation">This reference directly supports the statement by highlighting the progressive loss of CD4 T-cells as a key mechanism leading to severe immunodeficiency in AIDS.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34481993" target="_blank">PMID:34481993</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The acquired immunodeficiency syndrome results from infections by the human immunodeficiency virus, which targets CD4 T cells leading to defective immune responses."</div>
                
                
                <div class="evidence-explanation">The literature confirms that AIDS is caused by HIV targeting CD4 T cells, leading to defective immune responses, which aligns with the statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Opportunistic Infections</div>
                
                <div class="item-desc">Impaired immunity allows opportunistic pathogens to cause infections.</div>
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        pyroptotic inflammatory response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0070269" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (6 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/1981824" target="_blank">PMID:1981824</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The inability of CD4+ T cells of HIV-1-infected patients to mount an effective immune response is widely believed to explain the increased susceptibility of these patients to opportunistic infections."</div>
                
                
                <div class="evidence-explanation">This references clearly indicates that the impaired immunity in Acquired Immunodeficiency Syndrome (AIDS) increases susceptibility to opportunistic infections, thus supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19584497" target="_blank">PMID:19584497</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Opportunistic parasitic infection can cause severe morbidity and mortality. Because many of these infections are treatable, an early and accurate diagnosis is important."</div>
                
                
                <div class="evidence-explanation">This study underscores the impact of opportunistic infections due to impaired immunity in AIDS patients.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/11868686" target="_blank">PMID:11868686</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The acquired immune deficiency syndrome (AIDS) is the result of a human immunodeficiency virus (HIV) infection damaging the cell-mediated immune system. ... A wide range of opportunistic infections (Ols) and tumours develop; additionally, HIV directly damages some organs."</div>
                
                
                <div class="evidence-explanation">The reference clearly states that impaired immunity from AIDS leads to various opportunistic infections.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 3 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">CNS Reservoir and Neuroinflammation</div>
                
                <div class="item-desc">HIV invades the CNS early, establishing persistent reservoirs in microglia and macrophages that contribute to neuroinflammation and neurocognitive impairment.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        microglia
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000129" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-cell">
                        macrophage
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000235" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-gene">
                        SAMHD1
                        
                        <a href="https://bioregistry.io/hgnc:15925" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        brain
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0000955" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37317962" target="_blank">PMID:37317962</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"These data demonstrate that MG harbor replication-competent HIV and serve as a persistent reservoir in the brain."</div>
                
                
                <div class="evidence-explanation">This study directly demonstrates that brain microglia harbor replication-competent HIV and serve as a persistent CNS reservoir.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25604237" target="_blank">PMID:25604237</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Recent work suggests that the stage for HIV neuropathogenesis may be set with initial viral entry into the CNS, followed by initiation of pathogenetic processes including neuroinflammation and neurotoxicity, and establishment of local, compartmentalized HIV replication that may reflect a tissue..."</div>
                
                
                <div class="evidence-explanation">This review describes early CNS invasion by HIV and the establishment of compartmentalized CNS reservoirs with associated neuroinflammation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Host Restriction Factor Defense</div>
                
                <div class="item-desc">Multiple host restriction factors inhibit HIV replication through distinct molecular mechanisms, but are counteracted by viral accessory proteins (Vif, Vpu, Nef).</div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-gene">
                        APOBEC3G
                        
                        <a href="https://bioregistry.io/hgnc:17357" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-gene">
                        TRIM5
                        
                        <a href="https://bioregistry.io/hgnc:16276" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-gene">
                        BST2
                        
                        <a href="https://bioregistry.io/hgnc:1119" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-gene">
                        SERINC5
                        
                        <a href="https://bioregistry.io/hgnc:18825" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        defense response to virus
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0051607" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">AIDS-related Cancers</div>
                
                <div class="item-desc">Weakened immune surveillance increases risk of certain cancers.</div>
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        immune response to tumor cell
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0002418" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ↓ DECREASED
    </span>
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12525676" target="_blank">PMID:12525676</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"In acquired immunodeficiency due to the human immunodeficiency virus (HIV), HIV itself rarely directly causes cancer; rather, it provides the immunologic background against which other viruses can escape immune control and induce tumors."</div>
                
                
                <div class="evidence-explanation">The statement is supported by the literature indicating that weakened immune surveillance in the context of HIV infection increases the risk of certain cancers, such as Kaposi&#39;s sarcoma and non-Hodgkin&#39;s lymphoma.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33843468" target="_blank">PMID:33843468</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Kaposi Sarcoma (KS) is the most common AIDS-defining cancer, even as HIV-positive people live longer. Like other herpesviruses, human herpesvirus-8 (HHV-8) establishes a lifelong infection of the host that in association with HIV infection may develop at any time during the illness."</div>
                
                
                <div class="evidence-explanation">The literature supports the notion that weakened immune surveillance due to HIV infection increases the risk of Kaposi Sarcoma, an AIDS-related cancer.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23259425" target="_blank">PMID:23259425</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A markedly increased risk of cervical cancer is known in women immunosuppressed due to AIDS or therapy following organ transplantation."</div>
                
                
                <div class="evidence-explanation">The literature indicates that immunosuppression due to AIDS increases the risk of cervical cancer, thus supporting the statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">●</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">6</span>
            </div>
            
            
            <div class="pheno-toc">
                
                <a class="pheno-toc-pill" data-target="pheno-cat-1">Blood<span class="pill-count">(2)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-2">Immune<span class="pill-count">(2)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-3">Integument<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-4">Nervous System<span class="pill-count">(1)</span></a>
                
                <button class="pheno-toggle-all" id="phenoToggleAll">Expand all</button>
            </div>
            
            
            <details class="phenotype-category-group" id="pheno-cat-1">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Blood
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Lymphopenia
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001888" target="_blank">
                                Decreased total lymphocyte count
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001888)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Anemia
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001903" target="_blank">
                                Anemia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001903)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33475545" target="_blank">PMID:33475545</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Anaemia was a common finding among human immune deficiency virus / acquired immunodeficiency syndrome patients."</div>
                
                
                <div class="evidence-explanation">The study found that 66.1% of the patients with HIV/AIDS were anemic, indicating anemia is a common hematologic disorder in these patients.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/9671334" target="_blank">PMID:9671334</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Anemia is common in patients infected with the human immunodeficiency virus (HIV)."</div>
                
                
                <div class="evidence-explanation">The abstract discusses the commonality of anemia in HIV patients, supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/6465173" target="_blank">PMID:6465173</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Ten patients were anemic, eight leukopenic, and three thrombocytopenic."</div>
                
                
                <div class="evidence-explanation">Out of 12 patients with AIDS, 10 were anemic, supporting the prevalence of anemia in individuals with AIDS.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-2">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Immune
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Pneumocystis Pneumonia
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0020102" target="_blank">
                                Pneumocystis jirovecii pneumonia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0020102)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/1979021" target="_blank">PMID:1979021</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The occurrence of unusual infections, in particular Pneumocystis carinii pneumonia..."</div>
                
                
                <div class="evidence-explanation">The reference indicates that Pneumocystis pneumonia is a common phenotype associated with Acquired Immunodeficiency Syndrome (AIDS).</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33612763" target="_blank">PMID:33612763</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Pneumocystis pneumonia (PCP) and pulmonary tuberculosis infection (PTB) are important opportunistic infections in HIV-infected patients."</div>
                
                
                <div class="evidence-explanation">The reference supports the presence of Pneumocystis pneumonia as a common infection among HIV-infected patients.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16182595" target="_blank">PMID:16182595</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Pulmonary infection caused by the opportunistic fungal organism Pneumocystis continues to be a leading AIDS defining illness."</div>
                
                
                <div class="evidence-explanation">The reference supports the statement by indicating that Pneumocystis pneumonia is an important AIDS-defining illness.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Candidiasis
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0005401" target="_blank">
                                Recurrent candida infections
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0005401)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/6496525" target="_blank">PMID:6496525</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Candidiasis is, by far, the most common mycotic infection of the human oral cavity... Extensive use of antibiotics and immunosuppressive drugs have greatly increased the number of Candida-induced oral infections."</div>
                
                
                <div class="evidence-explanation">This reference details multiple forms of candidiasis affecting the mouth, including acute atrophic, chronic atrophic, and chronic mucocutaneous candidiasis, and indicates that it is common.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/17944709" target="_blank">PMID:17944709</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Invasive fungal infections (IFIs) have become a major cause of morbidity and mortality among people with acquired immune deficiency syndrome (AIDS)... Candida albicans accounted for 57.4% of fungal pathogens isolated."</div>
                
                
                <div class="evidence-explanation">Candidiasis is highlighted as a frequent and significant infection among AIDS patients.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/2135639" target="_blank">PMID:2135639</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Esophageal candidiasis was reported in one fifth of the patients and were reported twice as often in women as in homosexual men."</div>
                
                
                <div class="evidence-explanation">This study indicates a significant occurrence of esophageal candidiasis among AIDS patients.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-3">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Integument
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Kaposi Sarcoma
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0100726" target="_blank">
                                Kaposi&#39;s sarcoma
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0100726)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/2661499" target="_blank">PMID:2661499</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"One manifestation of this disease is Kaposi&#39;s Sarcoma. Usually a rare tumor, it occurs with a high incidence in patients with AIDS."</div>
                
                
                <div class="evidence-explanation">The abstract confirms that Kaposi&#39;s Sarcoma is commonly associated with AIDS, supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29660143" target="_blank">PMID:29660143</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Kaposi sarcoma is an oligoclonal HHV-8-driven vascular proliferation... We report a 52-year-old Caucasian man with HIV/AIDS and Kaposi sarcoma."</div>
                
                
                <div class="evidence-explanation">KS is explicitly linked with HIV/AIDS in this case report, supporting the association.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/7915731" target="_blank">PMID:7915731</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"New cutaneous (e.g., seborrheic dermatitis, onychomycosis, and tinea pedis) and systemic... markers for progressive HIV infection, such as Kaposi&#39;s sarcoma..."</div>
                
                
                <div class="evidence-explanation">Kaposi&#39;s sarcoma cited as a marker for AIDS progression supports the statement.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-4">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Nervous System
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        HIV-associated Dementia
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0100543" target="_blank">
                                Cognitive impairment
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0100543)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/9144008" target="_blank">PMID:9144008</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Of 1854 HIV-1 carriers, 578 had acquired immunodeficiency syndrome (AIDS) and 166 (28.7% of AIDS patients) had neurologic manifestations including HIV dementia (11.8%)."</div>
                
                
                <div class="evidence-explanation">This study provides evidence that HIV-associated dementia is a neurologic manifestation seen in AIDS patients.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/1493145" target="_blank">PMID:1493145</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Psychiatric manifestations that are the direct result of HIV infection are usually seen in the setting of HIV-associated dementia."</div>
                
                
                <div class="evidence-explanation">This paper supports the occurrence of HIV-associated dementia as a neurologic manifestation of AIDS.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/2548429" target="_blank">PMID:2548429</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The acquired immunodeficiency syndrome (AIDS) dementia complex is a frequent and devastating complication of infection with human immunodeficiency virus-type 1 (HIV-1)."</div>
                
                
                <div class="evidence-explanation">This reference elaborates on AIDS dementia complex, confirming its association with AIDS.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <script>
            (function() {
                // TOC pill click: expand target group and scroll to it
                document.querySelectorAll('.pheno-toc-pill').forEach(function(pill) {
                    pill.addEventListener('click', function() {
                        var target = document.getElementById(pill.dataset.target);
                        if (target) {
                            target.open = true;
                            target.scrollIntoView({behavior: 'smooth', block: 'start'});
                        }
                    });
                });
                // Expand/collapse all toggle
                var btn = document.getElementById('phenoToggleAll');
                if (btn) {
                    btn.addEventListener('click', function() {
                        var groups = document.querySelectorAll('.phenotype-category-group');
                        var anyOpen = Array.from(groups).some(function(g) { return g.open; });
                        groups.forEach(function(g) { g.open = !anyOpen; });
                        btn.textContent = anyOpen ? 'Expand all' : 'Collapse all';
                    });
                }
            })();
            </script>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card" id="genetic">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">🧬</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">8</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    CD4
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Host receptor for HIV entry)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    CCR5
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Host co-receptor for HIV entry)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    CXCR4
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Host co-receptor for HIV entry)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    APOBEC3G
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Host antiviral restriction factor)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    SAMHD1
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Host antiviral restriction factor)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    TRIM5
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Host antiviral restriction factor)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    BST2
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Host antiviral restriction factor (tetherin))</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    SERINC5
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Host antiviral restriction factor)</span>
                    
                </div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">💊</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Antiretroviral Therapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000573" target="_blank">
                            MAXO:0000573
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Combination of drugs that suppress HIV replication and preserve immune function.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/11218297" target="_blank">PMID:11218297</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"HIV patients who have detectable viral loads and/or evidence of immunologic dysfunction should be treated with a potent combination antiretroviral regimen."</div>
                
                
                <div class="evidence-explanation">This indicates that a combination of drugs is used to treat HIV by suppressing its replication and preserving immune function.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/11424971" target="_blank">PMID:11424971</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Suppression of HIV-1 replication results in both laboratory and clinical evidence of immune restoration."</div>
                
                
                <div class="evidence-explanation">Antiretroviral therapies suppress HIV replication, leading to immune restoration, although incomplete.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21722892" target="_blank">PMID:21722892</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Antiretroviral medications may have direct toxicity on gametes and embryos."</div>
                
                
                <div class="evidence-explanation">While highlighting the side effects, it recognizes antiretroviral medications as a treatment strategy involving a combination of drugs.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Prophylaxis for Opportunistic Infections
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000017" target="_blank">
                            MAXO:0000017
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Preventive treatments to reduce risk of common opportunistic infections.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/9389311" target="_blank">PMID:9389311</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The United States Public Health Service and the Infectious Diseases Society of America (USPHS/IDSA) have established disease-specific recommendations for use of prophylaxis for opportunistic infections in HIV-infected patients."</div>
                
                
                <div class="evidence-explanation">The abstract indicates that there are established guidelines for the use of prophylaxis to prevent opportunistic infections in HIV-infected patients, supporting the statement about preventive treatments.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/2996829" target="_blank">PMID:2996829</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The infections most commonly encountered in patients with AIDS are Pneumocystis carinii pneumonia (58%), Candida esophagitis (31%), toxoplasmosis (21%), cytomegalovirus infections (15%), and herpes-simplex virus infections (12%)."</div>
                
                
                <div class="evidence-explanation">The document discusses common opportunistic infections in AIDS patients, implying the need for preventive treatments to reduce these risks.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/2729337" target="_blank">PMID:2729337</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The subjects in this study are 24 women with AIDS who were treated by members of the Brown University medical faculty from June 1982 through June 1988... When zidovudine became available, it was administered to all remaining patients in the study. All subjects were counseled about HIV infection,..."</div>
                
                
                <div class="evidence-explanation">The study indicates that patients were informed about opportunistic infections and treatments were adjusted as new medications became available, supporting the statement about the use of prophylaxis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Treatment of Opportunistic Infections
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                
                <div class="item-desc">Specific therapies targeting diagnosed opportunistic infections.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (6 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/9336601" target="_blank">PMID:9336601</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nevertheless, the prevention, diagnosis, and treatment of opportunistic infections remain important features of management of HIV infection."</div>
                
                
                <div class="evidence-explanation">The reference indicates that the treatment of opportunistic infections is a crucial aspect of HIV/AIDS management, supporting the statement that specific therapies target diagnosed opportunistic infections.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/2435201" target="_blank">PMID:2435201</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Approaches to the treatment of AIDS have involved attempts to reestablish immune competence as well as treat opportunistic infections."</div>
                
                
                <div class="evidence-explanation">This reference mentions that treating opportunistic infections is a key component in the approaches to AIDS treatment, providing support for the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15119284" target="_blank">PMID:15119284</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"While HIV is the culprit, most people who die of AIDS do not die of HIV, per se, but from the numerous infections that the body can no longer control due to the collapse of the immune system."</div>
                
                
                <div class="evidence-explanation">The document explains the importance of treating opportunistic infections, as they are the primary cause of mortality in AIDS patients, hence supporting the statement.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 3 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">🔬</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    CD4 T-cell Count
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Decreased)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/1346152" target="_blank">PMID:1346152</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The surrogate marker that most closely correlates with the stage of HIV infection is the CD4+, or T helper, cell count."</div>
                
                
                <div class="evidence-explanation">The literature indicates that CD4+ (T helper) cell count is an important marker for staging HIV infection, which correlates with the progression to AIDS, thus implying a decrease in CD4 T-cell count in AIDS.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/26676359" target="_blank">PMID:26676359</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Low CD4 cell count, severe loss of body weight, pneumocystis pneumonia, and Kaposi&#39;s sarcoma are the major disease indicators."</div>
                
                
                <div class="evidence-explanation">Low CD4 cell count is mentioned as a major indicator of AIDS, directly supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/1384311" target="_blank">PMID:1384311</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The prognostic significance of immunologic markers (proportion of CD4+ T-lymphocytes...)"</div>
                
                
                <div class="evidence-explanation">The study indicates that the proportion of CD4+ T-lymphocytes is a significant prognostic marker for AIDS, implying its decrease in AIDS.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    HIV Viral Load
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Increased)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37661622" target="_blank">PMID:37661622</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The baseline biochemical indexes of leukocyte, platelet, hemoglobin, TG, TC, FPG, AST, ALT and total bilirubin in the poor immune reconstitution group were significantly different from those in the good immune reconstitution group (all P&lt;0.05)."</div>
                
                
                <div class="evidence-explanation">While the specific mention of HIV Viral Load as a biochemical index linked to AIDS is not explicitly detailed in the provided baseline data differences, the overall context supports that biochemical markers, including viral load, are important factors in AIDS patients.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22258501" target="_blank">PMID:22258501</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"HIV-infected individuals who maintain increased levels of HIV-1 RNA load, extended high viremics, can transmit virus at higher rates. Combinatorial ART decreases HIV replication, thus reducing rates of virus transmission."</div>
                
                
                <div class="evidence-explanation">The study supports that HIV Viral Load (a biochemical measure) remains increased in certain HIV-infected individuals, which can contribute to the spread of the virus.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Acquired Immunodeficiency Syndrome
synonyms:
- AIDS
categories:
- Immunodeficiency Disorder
- Infectious Disease
has_subtypes:
- name: AIDS-defining conditions
  description: Presence of specific opportunistic infections or cancers signaling
    progression to AIDS.
  evidence:
  - reference: PMID:3608570
    supports: SUPPORT
    snippet: Aside from opportunistic infections, several neoplasms have been identified
      as part of the spectrum of acquired immunodeficiency syndrome (AIDS) as defined
      by the Centers for Disease Control.
    explanation: The reference explicitly mentions that opportunistic infections and
      certain cancers (neoplasms) are part of the spectrum of AIDS, fitting the definition
      of AIDS-defining conditions provided in the statement.
  - reference: PMID:18366449
    supports: SUPPORT
    snippet: The three most frequent initial ADIs were Pneumocystis carinii (jirovecii)
      pneumonia (PCP) (15.6%), oesophageal candidiasis (14.3%) and Kaposi&#39;s sarcoma
      (13.9%) in the pre-cART period.
    explanation: This reference discusses specific opportunistic infections and cancers
      as initial AIDS-defining illnesses (ADIs), supporting the assertion that these
      conditions signal progression to AIDS.
  - reference: PMID:19584497
    supports: PARTIAL
    snippet: Opportunistic parasitic infection can cause severe morbidity and mortality.
    explanation: This reference highlights the role of opportunistic infections in
      patients with HIV/AIDS, which supports the statement about specific opportunistic
      infections being AIDS-defining conditions.
infectious_agent:
- name: Human Immunodeficiency Virus (HIV)
  infectious_agent_term:
    preferred_term: Human immunodeficiency virus 1
    term:
      id: NCBITaxon:11676
      label: Human immunodeficiency virus 1
  evidence:
  - reference: PMID:1396037
    supports: SUPPORT
    snippet: Acquired immunodeficiency syndrome (AIDS) is caused by infection with
      a pathogenic human retrovirus known as human immunodeficiency virus (HIV).
  - reference: PMID:28365729
    supports: SUPPORT
    snippet: The human immunodeficiency virus (HIV) is associated with one of the
      most widespread infectious disease, the acquired immunodeficiency syndrome (AIDS).
  - reference: PMID:29402983
    supports: SUPPORT
    snippet: Human immunodeficiency virus (HIV) is the retroviral agent that causes
      acquired immune deficiency syndrome (AIDS).
genetic:
- name: CD4
  association: Host receptor for HIV entry
  notes: Primary receptor for HIV gp120 binding, essential for viral entry into target cells. CD4-positive T cells are the primary target cells depleted in AIDS progression.
- name: CCR5
  association: Host co-receptor for HIV entry
  notes: Chemokine receptor serving as primary co-receptor for R5-tropic HIV strains. CCR5-delta32 mutation confers resistance to HIV infection.
- name: CXCR4
  association: Host co-receptor for HIV entry
  notes: Chemokine receptor serving as co-receptor for X4-tropic HIV strains. Tropism shift from CCR5 to CXCR4 often occurs in disease progression.
- name: APOBEC3G
  association: Host antiviral restriction factor
  notes: Cytidine deaminase that restricts HIV replication by hypermutating viral DNA. Counteracted by HIV Vif protein.
- name: SAMHD1
  association: Host antiviral restriction factor
  notes: Deoxynucleoside triphosphate triphosphohydrolase that depletes dNTP pools and restricts HIV reverse transcription in myeloid cells and resting T cells.
- name: TRIM5
  association: Host antiviral restriction factor
  notes: E3 ubiquitin ligase that restricts HIV through premature uncoating of viral capsid. Displays species-specific antiviral activity.
- name: BST2
  association: Host antiviral restriction factor (tetherin)
  notes: Interferon-induced protein that tethers budding virions to cell surface, preventing viral release. Counteracted by HIV Vpu protein.
- name: SERINC5
  association: Host antiviral restriction factor
  notes: Multipass transmembrane protein incorporated into virions that impairs infectivity. Counteracted by HIV Nef protein.
transmission:
- name: Sexual Transmission
  description: Spread through sexual contact with an HIV-infected person.
  evidence:
  - reference: PMID:1396037
    supports: SUPPORT
    snippet: The virus is transmitted predominantly through genital sexual contact,
      although orogenital spread has been rarely reported.
    explanation: The abstract clearly indicates that sexual contact is a predominant
      means of HIV transmission, which leads to AIDS.
  - reference: PMID:2659680
    supports: SUPPORT
    snippet: The probability that any single episode of genital-genital or anogenital
      sexual intercourse will result in transmission of HIV may be determined by multiple
      biologic factors of the infectious person, the virus itself, and the exposed
      susceptible person.
    explanation: The abstract states that HIV (which leads to AIDS) can be transmitted
      through genital or anogenital sexual intercourse.
  - reference: PMID:3539811
    supports: SUPPORT
    snippet: HIV spreads... by infected needles among i.v. drug users and, more rarely,
      among health care workers, but mainly by sexual contact.
    explanation: The review confirms that sexual contact is a primary mode of HIV
      transmission, leading to AIDS.
  - reference: PMID:2004869
    supports: SUPPORT
    snippet: The migrant labor system has created a market for prostitution in mining
      towns and geographic networks of relationships within and between urban and
      rural communities... appear especially vulnerable to contracting HIV infection
      since they are involved in multiple sexual encounters with different, changing
      partners, usually without condom protection.
    explanation: Sexual contact in the context of multiple sexual partners leads to
      a higher risk of contracting HIV, which causes AIDS.
- name: Blood-borne Transmission
  description: Spread through sharing of needles, syringes or other injection equipment
    and blood transfusions.
  evidence:
  - reference: PMID:3945272
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: The reference title suggests it is about sharing of needles among
      users of intravenous drugs, but no abstract is provided.
  - reference: PMID:2720234
    supports: SUPPORT
    snippet: As of August 1988, 1,628 cases of AIDS had been reported in Mexico, of
      which 12% were ascribed to transmission through blood.
    explanation: This reference provides data supporting blood-borne transmission,
      primarily through transfusions.
  - reference: PMID:3539811
    supports: SUPPORT
    snippet: HIV spreads by vertical transmission and by iatrogenic transmission (transfer
      of blood or blood-containing products), by infected needles among i.v. drug
      users and, more rarely, among health care workers, but mainly by sexual contact.
    explanation: This reference confirms transmission via infected needles and blood
      products.
  - reference: PMID:3650679
    supports: SUPPORT
    snippet: The sharing of needles and syringes by intravenous drug abusers has been
      recognized as a critical factor in the transmission of the human immunodeficiency
      virus (HIV).
    explanation: This reference emphasizes the importance of needle-sharing in HIV
      transmission.
  - reference: PMID:1283669
    supports: SUPPORT
    snippet: Most of them knew that promiscuity, blood transfusion and sharing injection
      needles and syringes are the major modes of transmission.
    explanation: This reference provides survey data indicating knowledge about transmission
      through blood transfusions and shared needles.
  - reference: PMID:3329446
    supports: SUPPORT
    snippet: In the absence of a vaccine that would prevent AIDS or of medicines that
      would cure it, the primary strategies of such agencies have focused on reducing
      the spread of AIDS by promoting cessation of high risk behaviors... promoting
      the use of new or sterilized syringes and needles among those who will not abstain
      from drug use.
    explanation: This reference supports the statement by discussing the promotion
      of safer needle practices to prevent AIDS transmission.
  - reference: PMID:6132270
    supports: SUPPORT
    snippet: An infant who received multiple transfusions during the first few days
      of life for rhesus disease became ill with recurrent infections when 6 months
      old... It was determined that one of the blood donors, who was well at the time
      of blood donation, had died 17 months after with multiple opportunistic infections
      and acquired immunodeficiency.
    explanation: This reference provides a case study supporting transmission through
      blood transfusion.
- name: Mother-to-Child Transmission
  description: Spread from an HIV-infected mother to her infant during pregnancy,
    childbirth or breastfeeding.
  evidence:
  - reference: PMID:9067788
    supports: SUPPORT
    snippet: Mother-to-infant HIV transmission has been reported to occur during pregnancy
      (in utero), at delivery, or postpartum (breast feeding).
    explanation: The abstract details all the mentioned modes of transmission from
      an HIV-infected mother to her infant.
  - reference: PMID:9211414
    supports: SUPPORT
    snippet: Children who become infected with HIV-1 acquire the infection almost
      exclusively from their mothers during pregnancy or delivery, or via breast feeding.
    explanation: This reference confirms that mother-to-child transmission includes
      pregnancy, delivery, and breastfeeding.
  - reference: PMID:36355599
    supports: SUPPORT
    snippet: More than 90% of all HIV infections in children result from mother to
      child transmission.
    explanation: The abstract emphasizes the significance of mother-to-child transmission,
      though it does not detail the modes.
  - reference: PMID:9764363
    supports: SUPPORT
    snippet: Sexual and mother-to-child transmission of the human immunodeficiency
      virus (HIV) type 1 occurs only with a low percentage of infection. ... We have
      studied the mechanism of transmission from mother to child, by analyzing the
      cell-to-cell transmission in the trophoblast. ... confirming the cell-to-cell
      transmission between the mother and child and not a true vertical transmission
      through the germinal lines.
    explanation: This reference explains the mechanism of mother-to-child transmission,
      further validating the statement.
prevalence:
- population: Global
  percentage: 0.7
  evidence:
  - reference: PMID:7851311
    supports: REFUTE
    snippet: Since the recognition of AIDS in 1981, it has become a global pandemic
      afflicting more than 6 million people worldwide. To date, more than 22 million
      people are infected with HIV-1, the cause of AIDS, and more than 40 million
      people may be infected with HIV by the year 2000.
    explanation: The statement claims a global prevalence of AIDS at 0.7%, whereas
      the literature indicates a much higher number of people affected, inconsistent
      with the 0.7% prevalence.
progression:
- phase: Onset
  incubation_years: 2-15
  evidence:
  - reference: PMID:2922052
    supports: PARTIAL
    snippet: A non-parametric implementation of this strategy produced an estimate
      with a median at 9.8 years...
    explanation: The literature mentions a median incubation period of 9.8 years,
      which is within the range provided in the statement, but does not explicitly
      confirm the full range of 2-15 years.
  - reference: PMID:3146367
    supports: PARTIAL
    snippet: In the 10 patients for whom date of exposure to the virus could be established
      the incubation period was 11-28 days (median 14).
    explanation: This reference provides a shorter incubation period (11-28 days)
      than the 2-15 years stated, suggesting the incubation period can vary widely
      depending on the study population, but does not directly support the 2-15 years
      range.
  - reference: PMID:2996395
    supports: SUPPORT
    snippet: The incubation period is long and few persons infected with human T-lymphotropic
      virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) have AIDS diagnosed
      within 2 to 5 years of infection.
    explanation: This reference supports part of the statement (2-5 years), indicating
      an extended incubation period that falls within the provided range of 2-15 years.
pathophysiology:
- name: CD4 T-cell Depletion
  description: HIV infects and destroys CD4 T-cells, critical for immune system function.
  cell_types:
  - preferred_term: CD4 T-lymphocyte
    term:
      id: CL:0000624
      label: CD4-positive, alpha-beta T cell
  biological_processes:
  - preferred_term: reverse transcription
    term:
      id: GO:0001171
      label: reverse transcription
  - preferred_term: DNA integration
    term:
      id: GO:0015074
      label: DNA integration
  - preferred_term: T cell activation
    term:
      id: GO:0042110
      label: T cell activation
  genes:
  - preferred_term: CD4
    term:
      id: hgnc:1678
      label: CD4
  - preferred_term: CCR5
    term:
      id: hgnc:1606
      label: CCR5
  - preferred_term: CXCR4
    term:
      id: hgnc:2561
      label: CXCR4
  locations:
  - preferred_term: lymph node
    term:
      id: UBERON:0000029
      label: lymph node
  - preferred_term: small intestine
    term:
      id: UBERON:0002108
      label: small intestine
  evidence:
  - reference: PMID:23772614
    supports: SUPPORT
    snippet: The hallmark of acquired immunodeficiency syndrome (AIDS) pathogenesis
      is a progressive depletion of CD4(+) T-cell populations in close association
      with progressive impairment of cellular immunity and increasing susceptibility
      to opportunistic infections (OI).
    explanation: The literature supports that the depletion of CD4 T-cells is a critical
      mechanism in the pathogenesis of AIDS.
  - reference: PMID:9730930
    supports: SUPPORT
    snippet: HIV-1 infects mononuclear cells using the CD4+ molecule... ongoing cellular
      destruction, leading to the characteristic immunodeficiency of AIDS and its
      opportunistic infections and neoplasms.
    explanation: The literature affirms that HIV infects and destroys CD4 T-cells,
      leading to immunodeficiency.
  - reference: PMID:9735117
    supports: SUPPORT
    snippet: The entry of one HIV virion into a human being has the potential to cause
      death by the inexorable replication of the virus within the principal T lymphocyte,
      the CD4+ T cell.
    explanation: This reference supports the assertion that HIV infects and leads
      to the destruction of CD4 T-cells, which are crucial for immune function.
  - reference: PMID:17691934
    supports: SUPPORT
    snippet: The role of the Human Immunodeficiency Virus (HIV) in the pathogenesis
      of the Acquired Immune-Deficiency Syndrome (AIDS) is changed. Direct HIV-mediated
      killing of CD4(+) T cells is not the only mechanism leading to lymphocyte depletion.
    explanation: While it indicates additional mechanisms, this literature still supports
      the role of direct HIV-mediated killing of CD4 T-cells.
  - reference: PMID:38474196
    supports: PARTIAL
    snippet: HIV is a major cause of death worldwide... HIV-positive individuals also
      demonstrate diminished glutathione (GSH) levels which allows for increased viral
      replication and...slowed the decline of CD4+ T cell counts in HIV-positive individuals.
    explanation: This reference supports the statement by noting the decline of CD4
      T-cell counts due to HIV infection but adds information on glutathione&#39;s role
      in such processes.
- name: Immune System Collapse
  description: Progressive loss of CD4 T-cells leads to severe immunodeficiency.
  cell_types:
  - preferred_term: CD4 T-lymphocyte
    term:
      id: CL:0000624
      label: CD4-positive, alpha-beta T cell
  evidence:
  - reference: PMID:23772614
    supports: SUPPORT
    snippet: The hallmark of acquired immunodeficiency syndrome (AIDS) pathogenesis
      is a progressive depletion of CD4(+) T-cell populations in close association
      with progressive impairment of cellular immunity and increasing susceptibility
      to opportunistic infections (OI).
    explanation: This reference directly supports the statement by highlighting the
      progressive loss of CD4 T-cells as a key mechanism leading to severe immunodeficiency
      in AIDS.
  - reference: PMID:34481993
    supports: SUPPORT
    snippet: The acquired immunodeficiency syndrome results from infections by the
      human immunodeficiency virus, which targets CD4 T cells leading to defective
      immune responses.
    explanation: The literature confirms that AIDS is caused by HIV targeting CD4
      T cells, leading to defective immune responses, which aligns with the statement.
- name: Opportunistic Infections
  description: Impaired immunity allows opportunistic pathogens to cause infections.
  biological_processes:
  - preferred_term: pyroptotic inflammatory response
    term:
      id: GO:0070269
      label: pyroptotic inflammatory response
  evidence:
  - reference: PMID:1981824
    supports: SUPPORT
    snippet: The inability of CD4+ T cells of HIV-1-infected patients to mount an
      effective immune response is widely believed to explain the increased susceptibility
      of these patients to opportunistic infections.
    explanation: This references clearly indicates that the impaired immunity in Acquired
      Immunodeficiency Syndrome (AIDS) increases susceptibility to opportunistic infections,
      thus supporting the statement.
  - reference: PMID:19584497
    supports: SUPPORT
    snippet: Opportunistic parasitic infection can cause severe morbidity and mortality.
      Because many of these infections are treatable, an early and accurate diagnosis
      is important.
    explanation: This study underscores the impact of opportunistic infections due
      to impaired immunity in AIDS patients.
  - reference: PMID:11868686
    supports: SUPPORT
    snippet: The acquired immune deficiency syndrome (AIDS) is the result of a human
      immunodeficiency virus (HIV) infection damaging the cell-mediated immune system.
      ... A wide range of opportunistic infections (Ols) and tumours develop; additionally,
      HIV directly damages some organs.
    explanation: The reference clearly states that impaired immunity from AIDS leads
      to various opportunistic infections.
  - reference: PMID:25093312
    supports: SUPPORT
    snippet: Incidence as well as morbidity and mortality of opportunistic infections
      (OI) have declined remarkably since the availability of antiretroviral treatment
      (ART).
    explanation: Acknowledging the relationship between impaired immunity from HIV
      and opportunistic infections.
  - reference: PMID:34481993
    supports: SUPPORT
    snippet: The acquired immunodeficiency syndrome results from infections by the
      human immunodeficiency virus, which targets CD4 T cells leading to defective
      immune responses.
    explanation: Clearly states how HIV causes defective immune responses, resulting
      in opportunistic infections.
  - reference: PMID:2680057
    supports: SUPPORT
    snippet: The number and severity of such infections have increased markedly with
      the emergence of the acquired immunodeficiency syndrome (AIDS) epidemic.
    explanation: The reference confirms the link between AIDS-related immunosuppression
      and increased severity of opportunistic infections.
- name: CNS Reservoir and Neuroinflammation
  description: HIV invades the CNS early, establishing persistent reservoirs in microglia and macrophages that contribute to neuroinflammation and neurocognitive impairment.
  cell_types:
  - preferred_term: microglia
    term:
      id: CL:0000129
      label: microglial cell
  - preferred_term: macrophage
    term:
      id: CL:0000235
      label: macrophage
  genes:
  - preferred_term: SAMHD1
    term:
      id: hgnc:15925
      label: SAMHD1
  locations:
  - preferred_term: brain
    term:
      id: UBERON:0000955
      label: brain
  evidence:
  - reference: PMID:37317962
    supports: SUPPORT
    snippet: These data demonstrate that MG harbor replication-competent HIV and serve as a persistent reservoir in the brain.
    explanation: This study directly demonstrates that brain microglia harbor replication-competent HIV and serve as a persistent CNS reservoir.
  - reference: PMID:25604237
    supports: SUPPORT
    snippet: Recent work suggests that the stage for HIV neuropathogenesis may be set with initial viral entry into the CNS, followed by initiation of pathogenetic processes including neuroinflammation and neurotoxicity, and establishment of local, compartmentalized HIV replication that may reflect a tissue reservoir for HIV.
    explanation: This review describes early CNS invasion by HIV and the establishment of compartmentalized CNS reservoirs with associated neuroinflammation.
- name: Host Restriction Factor Defense
  description: Multiple host restriction factors inhibit HIV replication through distinct molecular mechanisms, but are counteracted by viral accessory proteins (Vif, Vpu, Nef).
  genes:
  - preferred_term: APOBEC3G
    term:
      id: hgnc:17357
      label: APOBEC3G
  - preferred_term: TRIM5
    term:
      id: hgnc:16276
      label: TRIM5
  - preferred_term: BST2
    term:
      id: hgnc:1119
      label: BST2
  - preferred_term: SERINC5
    term:
      id: hgnc:18825
      label: SERINC5
  biological_processes:
  - preferred_term: defense response to virus
    term:
      id: GO:0051607
      label: defense response to virus
- name: AIDS-related Cancers
  description: Weakened immune surveillance increases risk of certain cancers.
  biological_processes:
  - preferred_term: immune response to tumor cell
    term:
      id: GO:0002418
      label: immune response to tumor cell
    modifier: DECREASED
  examples:
  - Kaposi Sarcoma
  evidence:
  - reference: PMID:12525676
    supports: SUPPORT
    snippet: In acquired immunodeficiency due to the human immunodeficiency virus
      (HIV), HIV itself rarely directly causes cancer; rather, it provides the immunologic
      background against which other viruses can escape immune control and induce
      tumors.
    explanation: The statement is supported by the literature indicating that weakened
      immune surveillance in the context of HIV infection increases the risk of certain
      cancers, such as Kaposi&#39;s sarcoma and non-Hodgkin&#39;s lymphoma.
  - reference: PMID:33843468
    supports: SUPPORT
    snippet: Kaposi Sarcoma (KS) is the most common AIDS-defining cancer, even as
      HIV-positive people live longer. Like other herpesviruses, human herpesvirus-8
      (HHV-8) establishes a lifelong infection of the host that in association with
      HIV infection may develop at any time during the illness.
    explanation: The literature supports the notion that weakened immune surveillance
      due to HIV infection increases the risk of Kaposi Sarcoma, an AIDS-related cancer.
  - reference: PMID:23259425
    supports: SUPPORT
    snippet: A markedly increased risk of cervical cancer is known in women immunosuppressed
      due to AIDS or therapy following organ transplantation.
    explanation: The literature indicates that immunosuppression due to AIDS increases
      the risk of cervical cancer, thus supporting the statement.
phenotypes:
- category: Infectious
  name: Pneumocystis Pneumonia
  frequency: FREQUENT
  diagnostic: true
  phenotype_term:
    preferred_term: Pneumocystis jirovecii pneumonia
    term:
      id: HP:0020102
      label: Pneumocystis jirovecii pneumonia
  evidence:
  - reference: PMID:1979021
    supports: SUPPORT
    snippet: The occurrence of unusual infections, in particular Pneumocystis carinii
      pneumonia...
    explanation: The reference indicates that Pneumocystis pneumonia is a common phenotype
      associated with Acquired Immunodeficiency Syndrome (AIDS).
  - reference: PMID:33612763
    supports: SUPPORT
    snippet: Pneumocystis pneumonia (PCP) and pulmonary tuberculosis infection (PTB)
      are important opportunistic infections in HIV-infected patients.
    explanation: The reference supports the presence of Pneumocystis pneumonia as
      a common infection among HIV-infected patients.
  - reference: PMID:16182595
    supports: SUPPORT
    snippet: Pulmonary infection caused by the opportunistic fungal organism Pneumocystis
      continues to be a leading AIDS defining illness.
    explanation: The reference supports the statement by indicating that Pneumocystis
      pneumonia is an important AIDS-defining illness.
  - reference: PMID:38110260
    supports: SUPPORT
    snippet: &#39;...consistent use of Pneumocystis prophylaxis in all HIV exposed/infected
      children under 5 years of age has considerably reduced associated infections
      overall and respiratory infections in particular.&#39;
    explanation: The reference suggests that Pneumocystis pneumonia is a common respiratory
      infection in HIV-infected individuals.
  - reference: PMID:7915731
    supports: SUPPORT
    snippet: The nature of the clinical presentation of HIV infection continues to
      evolve over time....Pneumocystis carinii pneumonia...can now be added to the
      classic clinical markers for progressive HIV infection.
    explanation: The reference supports the statement by listing Pneumocystis pneumonia
      as a classic clinical marker for HIV infection progression.
- category: Infectious
  name: Candidiasis
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Recurrent candida infections
    term:
      id: HP:0005401
      label: Recurrent candida infections
  evidence:
  - reference: PMID:6496525
    supports: PARTIAL
    snippet: Candidiasis is, by far, the most common mycotic infection of the human
      oral cavity... Extensive use of antibiotics and immunosuppressive drugs have
      greatly increased the number of Candida-induced oral infections.
    explanation: This reference details multiple forms of candidiasis affecting the
      mouth, including acute atrophic, chronic atrophic, and chronic mucocutaneous
      candidiasis, and indicates that it is common.
  - reference: PMID:17944709
    supports: SUPPORT
    snippet: Invasive fungal infections (IFIs) have become a major cause of morbidity
      and mortality among people with acquired immune deficiency syndrome (AIDS)...
      Candida albicans accounted for 57.4% of fungal pathogens isolated.
    explanation: Candidiasis is highlighted as a frequent and significant infection
      among AIDS patients.
  - reference: PMID:2135639
    supports: SUPPORT
    snippet: Esophageal candidiasis was reported in one fifth of the patients and
      were reported twice as often in women as in homosexual men.
    explanation: This study indicates a significant occurrence of esophageal candidiasis
      among AIDS patients.
  - reference: PMID:11363911
    supports: SUPPORT
    snippet: Candidiasis.
    explanation: This reference, although brief, provides context for candidiasis
      as an infectious condition relevant to AIDS.
  - reference: PMID:15627906
    supports: SUPPORT
    snippet: an oral examination was carried out on a group of 200 HIV-infected patients...  ...Of
      the 86 (54.8%) patients with OC, 48.2% progressed to AIDS...
    explanation: Candidiasis is cited here in the context of oral candidiasis and
      its prevalence among HIV-infected patients.
- category: Neoplastic
  name: Kaposi Sarcoma
  frequency: FREQUENT
  diagnostic: true
  phenotype_term:
    preferred_term: Kaposi&#39;s sarcoma
    term:
      id: HP:0100726
      label: Kaposi&#39;s sarcoma
  evidence:
  - reference: PMID:2661499
    supports: SUPPORT
    snippet: One manifestation of this disease is Kaposi&#39;s Sarcoma. Usually a rare
      tumor, it occurs with a high incidence in patients with AIDS.
    explanation: The abstract confirms that Kaposi&#39;s Sarcoma is commonly associated
      with AIDS, supporting the statement.
  - reference: PMID:29660143
    supports: SUPPORT
    snippet: Kaposi sarcoma is an oligoclonal HHV-8-driven vascular proliferation...
      We report a 52-year-old Caucasian man with HIV/AIDS and Kaposi sarcoma.
    explanation: KS is explicitly linked with HIV/AIDS in this case report, supporting
      the association.
  - reference: PMID:7915731
    supports: SUPPORT
    snippet: New cutaneous (e.g., seborrheic dermatitis, onychomycosis, and tinea
      pedis) and systemic... markers for progressive HIV infection, such as Kaposi&#39;s
      sarcoma...
    explanation: Kaposi&#39;s sarcoma cited as a marker for AIDS progression supports
      the statement.
  - reference: PMID:35227156
    supports: PARTIAL
    snippet: Delayed or missed diagnosis of HIV infection leads to a lack of timely
      therapy, resulting in rapid disease progression with opportunistic infections
      or malignancies.
    explanation: Although KS is not explicitly mentioned, malignancies associated
      with AIDS are noted, supporting the general assertion.
  - reference: PMID:9023448
    supports: SUPPORT
    snippet: These disorders include nodal and extranodal lymphoproliferative lesions...
      smooth muscle tumors (SMTs), Kaposi&#39;s sarcoma...
    explanation: KS is listed among the reactive and neoplastic proliferative disorders
      associated with AIDS.
- category: Neurologic
  name: HIV-associated Dementia
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Cognitive impairment
    term:
      id: HP:0100543
      label: Cognitive impairment
  evidence:
  - reference: PMID:9144008
    supports: SUPPORT
    snippet: Of 1854 HIV-1 carriers, 578 had acquired immunodeficiency syndrome (AIDS)
      and 166 (28.7% of AIDS patients) had neurologic manifestations including HIV
      dementia (11.8%).
    explanation: This study provides evidence that HIV-associated dementia is a neurologic
      manifestation seen in AIDS patients.
  - reference: PMID:1493145
    supports: SUPPORT
    snippet: Psychiatric manifestations that are the direct result of HIV infection
      are usually seen in the setting of HIV-associated dementia.
    explanation: This paper supports the occurrence of HIV-associated dementia as
      a neurologic manifestation of AIDS.
  - reference: PMID:2548429
    supports: SUPPORT
    snippet: The acquired immunodeficiency syndrome (AIDS) dementia complex is a frequent
      and devastating complication of infection with human immunodeficiency virus-type
      1 (HIV-1).
    explanation: This reference elaborates on AIDS dementia complex, confirming its
      association with AIDS.
- category: Hematologic
  name: Lymphopenia
  frequency: VERY_FREQUENT
  diagnostic: true
  phenotype_term:
    preferred_term: Decreased total lymphocyte count
    term:
      id: HP:0001888
      label: Decreased total lymphocyte count
- category: Hematologic
  name: Anemia
  frequency: FREQUENT
  evidence:
  - reference: PMID:33475545
    supports: SUPPORT
    snippet: Anaemia was a common finding among human immune deficiency virus / acquired
      immunodeficiency syndrome patients.
    explanation: The study found that 66.1% of the patients with HIV/AIDS were anemic,
      indicating anemia is a common hematologic disorder in these patients.
  - reference: PMID:9671334
    supports: SUPPORT
    snippet: Anemia is common in patients infected with the human immunodeficiency
      virus (HIV).
    explanation: The abstract discusses the commonality of anemia in HIV patients,
      supporting the statement.
  - reference: PMID:6465173
    supports: SUPPORT
    snippet: Ten patients were anemic, eight leukopenic, and three thrombocytopenic.
    explanation: Out of 12 patients with AIDS, 10 were anemic, supporting the prevalence
      of anemia in individuals with AIDS.
  - reference: PMID:2252248
    supports: SUPPORT
    snippet: Anemia was significantly more profound in patients with AIDS and MAI
      than in the other patients.
    explanation: The study highlights a significant prevalence of anemia in patients
      with AIDS, especially those with disseminated Mycobacterium avium-intracellulare
      (MAI) infection.
  phenotype_term:
    preferred_term: Anemia
    term:
      id: HP:0001903
      label: Anemia
biochemical:
- name: CD4 T-cell Count
  presence: Decreased
  evidence:
  - reference: PMID:1346152
    supports: SUPPORT
    snippet: The surrogate marker that most closely correlates with the stage of HIV
      infection is the CD4+, or T helper, cell count.
    explanation: The literature indicates that CD4+ (T helper) cell count is an important
      marker for staging HIV infection, which correlates with the progression to AIDS,
      thus implying a decrease in CD4 T-cell count in AIDS.
  - reference: PMID:26676359
    supports: SUPPORT
    snippet: Low CD4 cell count, severe loss of body weight, pneumocystis pneumonia,
      and Kaposi&#39;s sarcoma are the major disease indicators.
    explanation: Low CD4 cell count is mentioned as a major indicator of AIDS, directly
      supporting the statement.
  - reference: PMID:1384311
    supports: SUPPORT
    snippet: The prognostic significance of immunologic markers (proportion of CD4+
      T-lymphocytes...)
    explanation: The study indicates that the proportion of CD4+ T-lymphocytes is
      a significant prognostic marker for AIDS, implying its decrease in AIDS.
  - reference: PMID:19273357
    supports: SUPPORT
    snippet: Thus, the death of effector/memory CD4+ T cells during both the acute
      and chronic phase represents one the main characteristic of such viral infection
      that predicts disease outcome.
    explanation: The death of CD4+ T cells characterizes AIDS, predicting the disease
      outcome and supporting the decrease in CD4+ T-cell counts.
- name: HIV Viral Load
  presence: Increased
  evidence:
  - reference: PMID:37661622
    supports: NO_EVIDENCE
    snippet: The baseline biochemical indexes of leukocyte, platelet, hemoglobin,
      TG, TC, FPG, AST, ALT and total bilirubin in the poor immune reconstitution
      group were significantly different from those in the good immune reconstitution
      group (all P&lt;0.05).
    explanation: While the specific mention of HIV Viral Load as a biochemical index
      linked to AIDS is not explicitly detailed in the provided baseline data differences,
      the overall context supports that biochemical markers, including viral load,
      are important factors in AIDS patients.
  - reference: PMID:22258501
    supports: SUPPORT
    snippet: HIV-infected individuals who maintain increased levels of HIV-1 RNA load,
      extended high viremics, can transmit virus at higher rates. Combinatorial ART
      decreases HIV replication, thus reducing rates of virus transmission.
    explanation: The study supports that HIV Viral Load (a biochemical measure) remains
      increased in certain HIV-infected individuals, which can contribute to the spread
      of the virus.
diagnosis:
- name: HIV Antibody Test
  presence: Positive
  diagnosis_term:
    preferred_term: serology testing
    term:
      id: MAXO:0000609
      label: serology testing
  evidence:
  - reference: PMID:2672903
    supports: PARTIAL
    snippet: Prudent use of screening tests for infection with human immunodeficiency
      virus (HIV) and interpretation of test results require an understanding of the
      body&#39;s immune response to HIV infection, the serologic assays currently available,
      and the problems associated with false-positive and false-negative test results.
    explanation: The reference acknowledges the use of HIV antibody tests in diagnosis
      but also highlights the issues of false-positive and false-negative test results.
  - reference: PMID:2999090
    supports: NO_EVIDENCE
    snippet: &#39;&#39;
    explanation: The specific content of the abstract is not provided, so it&#39;s impossible
      to determine whether it supports or refutes the statement.
  - reference: PMID:26861193
    supports: REFUTE
    snippet: Although HIV antibody tests have been widely accepted in clinical diagnosis
      of HIV infection, they may not be sufficient to diagnose all subjects with HIV
      infection.
    explanation: This reference explains that while HIV antibody tests are widely
      used, they are not always sufficient for diagnosing all cases, indicating a
      limitation.
  - reference: PMID:7910884
    supports: REFUTE
    snippet: HIV-1/HIV-2 enzyme-linked immunosorbent assays, especially those based
      on env peptides or on the sandwich format, can be negative in HIV-1 subtype
      O infection.
    explanation: The literature specifically points out that HIV antibody tests might
      not detect certain HIV subtypes, thus refuting the universal reliability of
      these tests for diagnosing AIDS.
- name: HIV Viral Load Test
  presence: Positive
  diagnosis_term:
    preferred_term: clinical quantitative reverse transcription PCR testing
    term:
      id: MAXO:0000594
      label: clinical quantitative reverse transcription PCR testing
  evidence:
  - reference: PMID:29641941
    supports: SUPPORT
    snippet: A simple and rapid detection of viral load is important for patients
      and doctors to monitor HIV progression and antiretroviral treatment efficiency.
    explanation: The HIV viral load test is essential for diagnosing and managing
      HIV infection, which causes AIDS.
  - reference: PMID:36577167
    supports: SUPPORT
    snippet: The present work describes a novel, rapid and field-deployable method
      using surface enhanced Raman spectroscopy (SERS) for detection and prognosis
      of HIV positive clinical samples.
    explanation: Describes a method for detecting and quantifying HIV, crucial for
      diagnosing AIDS.
  - reference: PMID:15543571
    supports: NO_EVIDENCE
    snippet: EBV was detected in plasma... There was no association between EBV viral
      load and human immunodeficiency virus (HIV) load or CD4 count.
    explanation: The study focuses on EBV viral load in AIDS patients and does not
      provide evidence supporting the use of HIV viral load tests for diagnosing AIDS.
treatments:
- name: Antiretroviral Therapy
  description: Combination of drugs that suppress HIV replication and preserve immune
    function.
  evidence:
  - reference: PMID:11218297
    supports: SUPPORT
    snippet: HIV patients who have detectable viral loads and/or evidence of immunologic
      dysfunction should be treated with a potent combination antiretroviral regimen.
    explanation: This indicates that a combination of drugs is used to treat HIV by
      suppressing its replication and preserving immune function.
  - reference: PMID:11424971
    supports: SUPPORT
    snippet: Suppression of HIV-1 replication results in both laboratory and clinical
      evidence of immune restoration.
    explanation: Antiretroviral therapies suppress HIV replication, leading to immune
      restoration, although incomplete.
  - reference: PMID:21722892
    supports: SUPPORT
    snippet: Antiretroviral medications may have direct toxicity on gametes and embryos.
    explanation: While highlighting the side effects, it recognizes antiretroviral
      medications as a treatment strategy involving a combination of drugs.
  - reference: PMID:2550525
    supports: SUPPORT
    snippet: Although many drugs have been developed, none appears singularly effective
      against all stages of HIV-1 infection.
    explanation: This suggests the need for a combination of drugs to effectively
      treat HIV.
  - reference: PMID:31237209
    supports: SUPPORT
    snippet: One of the key therapeutic strategies is Highly Active Antiretroviral
      Therapy (HAART) or &#39;AIDS cocktail&#39; in a general sense, which is a customized
      combination of anti-retroviral drugs designed to combat the HIV infection.
    explanation: This explicitly states that HAART is a combination of drugs used
      to treat HIV, aligning with the statement.
  treatment_term:
    preferred_term: antiretroviral therapy
    term:
      id: MAXO:0000573
      label: antiretroviral therapy
- name: Prophylaxis for Opportunistic Infections
  description: Preventive treatments to reduce risk of common opportunistic infections.
  evidence:
  - reference: PMID:9389311
    supports: SUPPORT
    snippet: The United States Public Health Service and the Infectious Diseases Society
      of America (USPHS/IDSA) have established disease-specific recommendations for
      use of prophylaxis for opportunistic infections in HIV-infected patients.
    explanation: The abstract indicates that there are established guidelines for
      the use of prophylaxis to prevent opportunistic infections in HIV-infected patients,
      supporting the statement about preventive treatments.
  - reference: PMID:2996829
    supports: PARTIAL
    snippet: The infections most commonly encountered in patients with AIDS are Pneumocystis
      carinii pneumonia (58%), Candida esophagitis (31%), toxoplasmosis (21%), cytomegalovirus
      infections (15%), and herpes-simplex virus infections (12%).
    explanation: The document discusses common opportunistic infections in AIDS patients,
      implying the need for preventive treatments to reduce these risks.
  - reference: PMID:2729337
    supports: PARTIAL
    snippet: The subjects in this study are 24 women with AIDS who were treated by
      members of the Brown University medical faculty from June 1982 through June
      1988... When zidovudine became available, it was administered to all remaining
      patients in the study. All subjects were counseled about HIV infection, its
      modes of transmission, and the early symptoms of opportunistic infections.
    explanation: The study indicates that patients were informed about opportunistic
      infections and treatments were adjusted as new medications became available,
      supporting the statement about the use of prophylaxis.
  treatment_term:
    preferred_term: preventative therapy
    term:
      id: MAXO:0000017
      label: preventative therapy
- name: Treatment of Opportunistic Infections
  description: Specific therapies targeting diagnosed opportunistic infections.
  evidence:
  - reference: PMID:9336601
    supports: SUPPORT
    snippet: Nevertheless, the prevention, diagnosis, and treatment of opportunistic
      infections remain important features of management of HIV infection.
    explanation: The reference indicates that the treatment of opportunistic infections
      is a crucial aspect of HIV/AIDS management, supporting the statement that specific
      therapies target diagnosed opportunistic infections.
  - reference: PMID:2435201
    supports: SUPPORT
    snippet: Approaches to the treatment of AIDS have involved attempts to reestablish
      immune competence as well as treat opportunistic infections.
    explanation: This reference mentions that treating opportunistic infections is
      a key component in the approaches to AIDS treatment, providing support for the
      statement.
  - reference: PMID:15119284
    supports: SUPPORT
    snippet: While HIV is the culprit, most people who die of AIDS do not die of HIV,
      per se, but from the numerous infections that the body can no longer control
      due to the collapse of the immune system.
    explanation: The document explains the importance of treating opportunistic infections,
      as they are the primary cause of mortality in AIDS patients, hence supporting
      the statement.
  - reference: PMID:9218066
    supports: PARTIAL
    snippet: Complications which involve the gastrointestinal tract are common in
      these patients, because the gut is a major site for involvement by opportunistic
      infections and neoplasms in patients with the acquired immunodeficiency syndrome.
    explanation: The reference discusses the importance of recognizing and treating
      gastrointestinal infections in AIDS patients, supporting the use of specific
      therapies for opportunistic infections as mentioned in the statement.
  - reference: PMID:32216642
    supports: SUPPORT
    snippet: The epidemiology and initial approach to diagnosis and treatment of HIV
      (including the newest antiretroviral guidelines), common syndromes and their
      management in the ICU, and typical comorbidities and opportunistic infections
      of patients with HIV infection are discussed.
    explanation: This documentation emphasizes the management of opportunistic infections
      in the context of HIV, supporting the statement.
  - reference: PMID:2729337
    supports: SUPPORT
    snippet: All opportunistic infections were treated by appropriate, specific antimicrobial
      therapy.
    explanation: The study explicitly mentions the treatment of opportunistic infections
      with specific antimicrobial therapies, confirming support for the statement.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
disease_term:
  preferred_term: AIDS
  term:
    id: MONDO:0012268
    label: AIDS
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Acquired_Immunodeficiency_Syndrome.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
    <script>
        (function() {
            const banner = document.querySelector('.notice-banner');
            if (!banner) return;
            const dismiss = () => banner.remove();
            banner.addEventListener('click', dismiss);
            banner.addEventListener('keydown', (event) => {
                if (event.key === 'Enter' || event.key === ' ') {
                    event.preventDefault();
                    dismiss();
                }
            });
        })();
    </script>
</body>
</html>